Within-host competition and drug resistance in the human malaria parasite plasmodium falciparum

Proceedings of the Royal Society B: Biological Sciences

Volumn 283, Issue 1826, 2016, Pages

  Bushman, Mary ^a,b   Morton, Lindsay ^b   Duah, Nancy ^c   Quashie, Neils ^c,d   Abuaku, Benjamin ^c   Koram, Kwadwo A ^c   Dimbu, Pedro Rafael ^e   Plucinski, Mateusz ^b   Gutman, Julie ^b   Lyaruu, Peter ^f   Patrick Kachur, S ^b   de Roode, Jacobus C ^a   Udhayakumar, Venkatachalam ^b  

^a EMORY UNIVERSITY   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c University of Ghana   (Ghana)

^d UNIVERSITY OF GHANA   (Ghana)

^e University of Ghana Medical School ^*  (Angola)

^f IFAKARA HEALTH INSTITUTE   (Tanzania)

Author keywords

Chloroquine; Competition; Malaria; Plasmodium falciparum; Resistance; Within host

Indexed keywords

DISEASE VECTOR; DRUG; DRUG DEVELOPMENT; DRUG RESISTANCE; HOST USE; MALARIA; MOSQUITO; PARASITE; PEST CONTROL;

ANGOLA; GHANA;

PLASMODIUM FALCIPARUM;

ANTIMALARIAL AGENT; CHLOROQUINE;

ANGOLA; CHILD; DRUG EFFECTS; DRUG RESISTANCE; GENETICS; GHANA; HUMAN; INFANT; MALARIA, FALCIPARUM; NEWBORN; PARASITOLOGY; PHYSIOLOGY; PLASMODIUM FALCIPARUM; PRESCHOOL CHILD; TANZANIA;

ANGOLA; ANTIMALARIALS; CHILD; CHILD, PRESCHOOL; CHLOROQUINE; DRUG RESISTANCE; GHANA; HUMANS; INFANT; INFANT, NEWBORN; MALARIA, FALCIPARUM; PLASMODIUM FALCIPARUM; TANZANIA;

EID: 84962500728     PISSN: 09628452     EISSN: 14712954     Source Type: Journal    
DOI: 10.1098/rspb.2015.3038     Document Type: Article

References (58)

1. Cohen ML. 2000 Changing patterns of infectious disease. Nature 406, 762–767. (doi:10.1038/35021206)
2. Wootton JC, Feng X, Ferdig MT, Cooper RA, Mu J, Baruch DI, Magill AJ, Su X. 2002 Genetic diversity and chloroquine selective sweeps in Plasmodium falciparum. Nature 418, 320–323. (doi:10.1038/nature00813)
3. Roper C, Pearce R, Nair S, Sharp B, Nosten F, Anderson T. 2004 Intercontinental spread of pyrimethamine-resistant malaria. Science 305, 1124. (doi:10.1126/science.1098876)
4. Ashley EA et al. 2014 Spread of artemisinin resistance in Plasmodium falciparum malaria. N. Engl. J. Med. 371, 411–423. (doi:10.1056/NEJMoa1314981)
5. Dondorp AM et al. 2009 Artemisinin resistance in Plasmodium falciparum malaria. N. Engl. J. Med. 361, 455–467. (doi:10.1056/NEJMoa0808859)
6. Birger RB, Kouyos RD, Cohen T, Griffiths EC, Huijben S, Mina M, Volkova V, Grenfell B, Metcalf CJE. 2015 The potential impact of coinfection on antimicrobial chemotherapy and drug resistance. Trends Microbiol. 23, 537–544. (doi:10.1016/j.tim.2015.05.002)
7. Read AF, Taylor LH. 2001 The ecology of genetically diverse infections. Science 292, 1099–1102. (doi:10.1126/science.1059410)
8. Arnot D. 1998 Unstable malaria in Sudan: the influence of the dry season: clone multiplicity of Plasmodium falciparum infections in individuals exposed to variable levels of disease transmission. Trans. R. Soc. Trop. Med. Hyg. 92, 580–585. (doi:10.1016/S0035-9203(98)90773-8)
9. Juliano JJ, Porter K, Mwapasa V, Sem R, Rogers WO, Ariey F, Wongsrichanalai C, Read A, Meshnick SR. 2010 Exposing malaria in-host diversity and estimating population diversity by capture-recapture using massively parallel pyrosequencing. Proc. Natl Acad. Sci. USA 107, 20 138–20 143. (doi:10.1073/pnas.1007068107)
10. de Roode JC, Culleton R, Bell AS, Read AF. 2004 Competitive release of drug resistance following drug treatment of mixed Plasmodium chabaudi infections. Malar. J. 3, 33. (doi:10.1186/1475-2875-3-33)
11. De Roode JC, Read AF, Chan BHK, Mackinnon MJ. 2003 Rodent malaria parasites suffer from the presence of conspecific clones in three-clone Plasmodium chabaudi infections. Parasitology 127, 411–418. (doi:10.1017/S0031182003004001)
12. Day T, Huijben S, Read AF. 2015 Is selection relevant in the evolutionary emergence of drug resistance? Trends Microbiol. 23, 126–133. (doi:10.1016/j.tim.2015.01.005)
13. Klein EY, Smith DL, Laxminarayan R, Levin S. 2012 Superinfection and the evolution of resistance to antimalarial drugs. Proc. R. Soc. B 279, 3834–3842. (doi:10.1098/rspb.2012.1064)
14. Hastings IM. 1997 A model for the origins and spread of drug-resistant malaria. Parasitology 115, 133–141. (doi:10.1017/S0031182097001261)
15. Hastings IM, D’Alessandro U. 2000 Modelling a predictable disaster: the rise and spread of drugresistant malaria. Parasitol. Today 16, 340–347. (doi:10.1016/S0169-4758(00)01707-5)
16. Hansen J, Day T. 2014 Coinfection and the evolution of drug resistance. J. Evol. Biol. 27, 2595–2604. (doi:10.1111/jeb.12518)
17. Wargo AR, Huijben S, de Roode JC, Shepherd J, Read AF. 2007 Competitive release and facilitation of drug-resistant parasites after therapeutic chemotherapy in a rodent malaria model. Proc. Natl Acad. Sci. USA 104, 19 914–19 919. (doi:10.1073/pnas.0707766104)
18. Bell AS, Huijben S, Paaijmans KP, Sim DG, Chan BH, Nelson WA, Read AF. 2012 Enhanced transmission of drug-resistant parasites to mosquitoes following drug treatment in rodent malaria. PLoS ONE 7, e37172. (doi:10.1371/journal.pone.0037172)
19. Pollitt LC, Huijben S, Sim DG, Salathe RM, Jones MJ, Read AF. 2014 Rapid response to selection, competitive release and increased transmission potential of artesunate-selected Plasmodium chabaudi malaria parasites. PLoS Pathog. 10, e1004019. (doi:10.1371/journal.ppat.1004019)
20. de Roode JC, Helinski MEH, Anwar MA, Read AF. 2005 Dynamics of multiple infection and within-host competition in genetically diverse malaria infections. Am. Nat. 166, 531–542. (doi:10.1086/491659)
21. Huijben S, Nelson WA, Wargo AR, Sim DG, Drew DR, Read AF. 2010 Chemotherapy, within-host ecology and the fitness of drug-resistant malaria parasites. Evolution 64, 2952–2968. (doi:10.1111/j.1558-5646.2010.01068.x)
22. Huijben S, Sim DG, Nelson WA, Read AF. 2011 The fitness of drug-resistant malaria parasites in a rodent model: multiplicity of infection. J. Evol. Biol. 24, 2410–2422. (doi:10.1111/j.1420-9101.2011.02369.x)
23. Stephens R, Culleton RL, Lamb TJ. 2012 The contribution of Plasmodium chabaudi to our understanding of malaria. Trends Parasitol. 28, 73–82. (doi:10.1016/j.pt.2011.10.006)
24. Borrmann S, Matuschewski K. 2011 Protective immunity against malaria by ‘natural immunization’: a question of dose, parasite diversity, or both? Curr. Opin. Immunol. 23, 500–508. (doi:10.1016/j.coi.2011.05.009)
25. Bruce MC, Donnelly CA, Alpers MP, Galinski MR, Barnwell JW, Walliker D, Day KP. 2000 Cross-species interactions between malaria parasites in humans. Science 287, 845–848. (doi:10.1126/science.287.5454.845)
26. Harrington WE, Mutabingwa TK, Muehlenbachs A, Sorensen B, Bolla MC, Fried M, Duffy PE. 2009 Competitive facilitation of drug-resistant Plasmodium falciparum malaria parasites in pregnant women who receive preventive treatment. Proc. Natl Acad. Sci. USA 106, 9027–9032. (doi:10.1073/pnas.0901415106)
27. Ecker A, Lehane AM, Clain J, Fidock DA. 2012 PfCRT and its role in antimalarial drug resistance. Trends Parasitol. 28, 504–514. (doi:10.1016/j.pt.2012.08.002)
28. Naidoo I, Roper C. 2013 Mapping ‘partially resistant’, ‘fully resistant’, and ‘super resistant’ malaria. Trends Parasitol. 29, 505–515. (doi:10.1016/j.pt.2013.08.002)
29. World Health Organization. 2009 Methods for surveillance of antimalarial drug efficacy. Geneva, Switzerland: World Health Organization.
30. Plucinski MM, Talundzic E, Morton L, Dimbu PR, Macaia AP, Fortes F, Goldman I, Lucchi N, Stennies G, MacArthur JR. 2015 Efficacy of artemether-lumefantrine and dihydroartemisinin-piperaquine for treatment of uncomplicated malaria in children in Zaire and Uíge provinces, Angola. Antimicrob. Agents Chemother. 59, 437–443. (doi:10.1128/AAC.04181-14)
31. Alam MT et al. 2011 Selective sweeps and genetic lineages of Plasmodium falciparum drug-resistant alleles in Ghana. J. Infect. Dis. 203, 220–227. (doi:10.1093/infdis/jiq038)
32. Alifrangis M et al. 2006 Occurrence of the Southeast Asian/South American SVMNT haplotype of the chloroquine-resistance transporter gene in Plasmodium falciparum in Tanzania. J. Infect. Dis. 193, 1738–1741. (doi:10.1086/504269)
33. Fancony C, Gamboa D, Sebastiao Y, Hallett R, Sutherland C, Sousa-Figueiredo JC, Nery SV. 2012 Various pfcrt and pfmdr1 genotypes of Plasmodium falciparum cocirculate with P. malariae, P. ovale spp., and P. vivax in northern Angola. Antimicrob. Agents Chemother. 56, 5271–5277. (doi:10.1128/AAC.00559-12)
34. Gama BE, Pereira-Carvalho GA, Lutucuta Kosi FJ, Almeida de Oliveira NK, Fortes F, Rosenthal PJ, Daniel-Ribeiro CT, de Fa´tima Ferreira-da-Cruz M. 2010 Plasmodium falciparum isolates from Angola show the StctVMNT haplotype in the pfcrt gene. Malar. J. 9, 174. (doi:10.1186/1475-2875-9-174)
35. R Core Team. 2012 R: a language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing.
36. Crawley MJ. 2013 The R book, 2nd edn. New York, NY: John Wiley & Sons.
37. Bates D, Maechler M, Bolker B. 2015 lme4: Linear mixed-effects models using S4 classes. R package version 0.999375-42. See http://cran.r-project.org/ package=lme4.
38. Pinheiro J, Bates D, DebRoy S, Sarkar D. 2015 nlme: linear and nonlinear mixed effects models 2015. R package version 3.1-122.
39. Browne WJ, Subramanian SV, Jones K, Goldstein H. 2005 Variance partitioning in multilevel logistic models that exhibit overdispersion. J. R. Stat. Soc. A 168, 599–613. (doi:10.1111/j.1467-985X.2004.00365.x)
40. Babiker HA, Hastings IM, Swedberg G. 2009 Impaired fitness of drug-resistant malaria parasites: evidence and implication on drug-deployment policies. Expert Rev. Anti-Infect. Ther. 7, 581–593. (doi:10.1586/eri.09.29)
41. Gething PW, Patil AP, Smith DL, Guerra CA, Elyazar IR, Johnston GL, Tatem AJ, Hay SI. 2011 A new world malaria map: Plasmodium falciparum endemicity in 2010. Malar. J. 10, 378. (doi:10.1186/1475-2875-10-378)
42. Ord R, Alexander N, Dunyo S, Hallett R, Jawara M, Targett G, Drakeley CJ, Sutherland CJ. 2007 Seasonal carriage of pfcrt and pfmdr1 alleles in Gambian Plasmodium falciparum imply reduced fitness of chloroquine-resistant parasites. J. Infect. Dis. 196, 1613–1619. (doi:10.1086/522154)
43. Kublin JG et al. 2003 Reemergence of chloroquinesensitive Plasmodium falciparum malaria after cessation of chloroquine use in Malawi. J. Infect. Dis. 187, 1870–1875. (doi:10.1086/375419)
44. Bruce MC, Day KP. 2002 Cross-species regulation of malaria parasitaemia in the human host. Curr. Opin. Microbiol. 5, 431–437. (doi:10.1016/S1369-5274(02)00348-X)
45. Metcalf CJ, Graham AL, Huijben S, Barclay VC, Long GH, Grenfell BT, Read AF, Bjornstad ON. 2011 Partitioning regulatory mechanisms of within-host malaria dynamics using the effective propagation number. Science 333, 984–988. (doi:10.1126/science.1204588)
46. Raberg L, de Roode JC, Bell AS, Stamou P, Gray D, Read AF. 2006 The role of immune-mediated apparent competition in genetically diverse malaria infections. Am. Nat. 168, 41–53. (doi:10.1086/505160)
47. Yap GS, Stevenson MM. 1994 Blood transfusion alters the course and outcome of Plasmodium chabaudi AS infection in mice. Infect. Immun. 62, 3761–3765.
48. Mideo N, Kennedy DA, Carlton JM, Bailey JA, Juliano JJ, Read AF. 2013 Ahead of the curve: next generation estimators of drug resistance in malaria infections. Trends Parasitol. 29, 321–328. (doi:10.1016/j.pt.2013.05.004)
49. Mackinnon MJ, Read AF. 2004 Virulence in malaria: an evolutionary viewpoint. Phil. Trans. R. Soc. Lond. B 359, 965–986. (doi:10.1098/rstb.2003.1414)
50. Ross A, Killeen G, Smith T. 2006 Relationships between host infectivity to mosquitoes and asexual parasite density in Plasmodium falciparum. Am. J. Trop. Med. Hyg. 75, 32–37.
51. Read AF, Day T, Huijben S. 2011 The evolution of drug resistance and the curious orthodoxy of aggressive chemotherapy. Proc. Natl Acad. Sci. USA 108(Suppl. 2), 10 871–10 877. (doi:10.1073/pnas.1100299108)
52. Kumpornsin K et al. 2014 Origin of robustness in generating drug-resistant malaria parasites. Mol. Biol. Evol. 31, 1649–1660. (doi:10.1093/molbev/msu140)
53. Hall AR, MacLean RC. 2011 Epistasis buffers the fitness effects of rifampicin-resistance mutations in Pseudomonas aeruginosa. Evolution 65, 2370– 2379. (doi:10.1111/j.1558-5646.2011.01302.x)
54. Lukens AK, Ross LS, Heidebrecht R, Javier Gamo F, Lafuente-Monasterio MJ, Booker ML, Hartl DL, Wiegand RC, Wirth DF. 2014 Harnessing evolutionary fitness in Plasmodium falciparum for drug discovery and suppressing resistance. Proc. Natl Acad. Sci. USA 111, 799–804. (doi:10.1073/pnas.1320886110)
55. Lindblade KA, Steinhardt L, Samuels A, Kachur SP, Slutsker L. 2013 The silent threat: asymptomatic parasitemia and malaria transmission. Expert Rev. Anti-Infect. Ther. 11, 623–639. (doi:10.1586/eri.13.45)
56. Huijben S, Bell AS, Sim DG, Tomasello D, Mideo N, Day T, Read AF. 2013 Aggressive chemotherapy and the selection of drug resistant pathogens. PLoS Pathog. 9, e1003578. (doi:10.1371/journal.ppat.1003578)
57. Kouyos RD et al. 2014 The path of least resistance: aggressive or moderate treatment? Proc R. Soc. B 281, 20140566. (doi:10.1098/rspb.2014.0566)
58. Hastings IM. 2011 Why we should effectively treat malaria. Trends Parasitol. 27, 51–52. (doi:10.1016/j.pt.2010.10.003)